Cargando…

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

BACKGROUND: The death receptors TRAIL-R1 and TRAIL-R2 are frequently overexpressed in cancer and there is an emerging evidence for their important role in malignant progression, also in the case of pancreatic ductal adenocarcinoma (PDAC). In their canonical localization at the plasma membrane, TRAIL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gundlach, Jan-Paul, Hauser, Charlotte, Schlegel, Franka Maria, Böger, Christine, Röder, Christian, Röcken, Christoph, Becker, Thomas, Egberts, Jan-Hendrik, Kalthoff, Holger, Trauzold, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069838/ https://www.ncbi.nlm.nih.gov/pubmed/30064384 http://dx.doi.org/10.1186/s12885-018-4688-8

Ejemplares similares

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
por: Legler, Karen, et al.
Publicado: (2018)

CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells
por: Rashid, Khalid, et al.
Publicado: (2021)

Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
por: Bertsch, U, et al.
Publicado: (2014)

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
por: Miarka, Lauritz, et al.
Publicado: (2019)

TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
por: Voigt, Susann, et al.
Publicado: (2014)

Comparative Analysis of Blood and Bone Marrow for the Detection of Circulating and Disseminated Tumor Cells and Their Prognostic and Predictive Value in Esophageal Cancer Patients
por: Richter, Florian, et al.
Publicado: (2020)

Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases
por: Born, Johanna, et al.
Publicado: (2021)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

Integrins α(v)β(3) and α(v)β(5) as prognostic, diagnostic, and therapeutic targets in gastric cancer
por: Böger, Christine, et al.
Publicado: (2014)

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
por: Böger, Christine, et al.
Publicado: (2016)

Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model
por: Tiwari, Sanjay, et al.
Publicado: (2011)

Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts
por: Heits, Nils, et al.
Publicado: (2016)

NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023)

TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
por: Fritsche, Hendrik, et al.
Publicado: (2015)

Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells
por: Ammerpohl, O, et al.
Publicado: (2007)

NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019)

Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer
por: Lascorz, Jesus, et al.
Publicado: (2012)

Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers
por: Goody, Deborah, et al.
Publicado: (2019)

Detection of Circulating and Disseminated Tumor Cells and Their Prognostic Value under the Influence of Neoadjuvant Therapy in Esophageal Cancer Patients
por: Richter, Florian, et al.
Publicado: (2022)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma
por: Hendricks, Alexander, et al.
Publicado: (2018)

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)

Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
por: Speth, Cornelia, et al.
Publicado: (2022)

c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
por: Geismann, C, et al.
Publicado: (2014)

Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients – a prospective study
por: Hinz, Sebastian, et al.
Publicado: (2017)

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015)

Paracrine Interaction of Cholangiocellular Carcinoma with Cancer-Associated Fibroblasts and Schwann Cells Impact Cell Migration
por: Gundlach, Jan-Paul, et al.
Publicado: (2022)

Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer
por: Wilhelm, Franziska, et al.
Publicado: (2016)

The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma
por: Ling, Qi, et al.
Publicado: (2017)

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
por: Böger, C., et al.
Publicado: (2017)

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022)

Lethal thrombosis of the iliac artery caused by Aspergillus fumigatus after liver transplantation: case report and review of the literature
por: Gundlach, Jan-Paul, et al.
Publicado: (2019)

Expression of TRAIL-splice variants in gastric carcinomas: identification of TRAIL-γ as a prognostic marker
por: Krieg, Andreas, et al.
Publicado: (2013)

Therapy Resistance in Neoadjuvantly Treated Gastric Cancer and Cancer of the Gastroesophageal Junction is Associated with an Increased Expression of Immune Checkpoint Inhibitors—Comparison Against a Therapy Naïve Cohort
por: Schoop, Hauke, et al.
Publicado: (2019)

Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
por: Philipp, Stephan, et al.
Publicado: (2015)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response
por: Freiin Grote, Antonia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n3dm7nkict5hfrpc4b5vncqa79